In pediatric rheumatologic disease, methotrexate leads to mildly changed bloodwork on the second day after administration

Detalles Bibliográficos
Autores principales: Hugle, Boris, Fischer, Nadine, Haas, Johannes-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991882/
https://www.ncbi.nlm.nih.gov/pubmed/35392929
http://dx.doi.org/10.1186/s12969-022-00685-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991882/
https://www.ncbi.nlm.nih.gov/pubmed/35392929
http://dx.doi.org/10.1186/s12969-022-00685-8

Ejemplares similares